Astera Labs (NASDAQ:ALAB) CEO Jitendra Mohan Sells 90,459 Shares

Astera Labs, Inc. (NASDAQ:ALAB) CEO Jitendra Mohan sold 90,459 shares of the company’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the completion of the sale, the chief executive officer owned 2,080,418 shares in the company, valued at $301,015,680.42. The trade was a 4.17% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link.

Jitendra Mohan also recently made the following trade(s):

• On Monday, November 17th, Jitendra Mohan sold 90,459 shares of Astera Labs stock. The shares were sold at an average price of $144.69, for a total value of $13,088,512.71.

Astera Labs Stock Up 1.8%

Shares of NASDAQ ALAB traded up $2.49 during trading on Wednesday, reaching $142.01. The company had a trading volume of 4,125,472 shares, compared to its average volume of 5,263,438. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90. The stock has a market cap of $23.99 billion, a PE ratio of 127.94, a P/E/G ratio of 2.64 and a beta of 1.37. The business’s 50-day moving average is $190.50 and its 200 day moving average is $145.33.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $0.10. The firm had revenue of $230.58 million during the quarter, compared to analyst estimates of $206.42 million. Astera Labs had a return on equity of 13.48% and a net margin of 27.50%.Astera Labs’s quarterly revenue was up 103.9% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.23 EPS. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current year.

Wall Street Analyst Weigh In

Several research analysts have recently issued reports on ALAB shares. TD Cowen dropped their target price on shares of Astera Labs from $225.00 to $170.00 and set a “hold” rating on the stock in a research note on Wednesday, November 5th. CICC Research began coverage on shares of Astera Labs in a report on Friday, August 29th. They issued an “outperform” rating and a $190.00 price objective for the company. Cowen reaffirmed a “hold” rating on shares of Astera Labs in a research report on Wednesday, November 5th. Northland Capmk raised Astera Labs from a “hold” rating to a “strong-buy” rating in a report on Monday. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Astera Labs in a research note on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, fourteen have issued a Buy rating and seven have given a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $184.82.

Institutional Investors Weigh In On Astera Labs

A number of hedge funds have recently added to or reduced their stakes in the stock. Alliancebernstein L.P. increased its position in Astera Labs by 114.2% during the first quarter. Alliancebernstein L.P. now owns 8,401,019 shares of the company’s stock valued at $501,289,000 after acquiring an additional 4,478,741 shares during the last quarter. Atreides Management LP grew its stake in shares of Astera Labs by 153.3% during the 1st quarter. Atreides Management LP now owns 4,652,264 shares of the company’s stock valued at $277,601,000 after purchasing an additional 2,815,614 shares during the period. Vanguard Group Inc. grew its stake in shares of Astera Labs by 29.6% during the 2nd quarter. Vanguard Group Inc. now owns 12,049,223 shares of the company’s stock valued at $1,089,491,000 after purchasing an additional 2,751,747 shares during the period. Amundi increased its position in shares of Astera Labs by 1,298.6% during the 3rd quarter. Amundi now owns 1,421,263 shares of the company’s stock valued at $278,283,000 after purchasing an additional 1,319,643 shares during the last quarter. Finally, FengHe Fund Management Pte. Ltd. bought a new position in shares of Astera Labs in the 2nd quarter worth approximately $106,772,000. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

About Astera Labs

Astera Labs, Inc designs, manufactures, and sells semiconductor-based connectivity solutions for cloud and AI infrastructure. Its Intelligent Connectivity Platform is comprised of a portfolio of data, network, and memory connectivity products, which are built on a unifying software-defined architecture that enables customers to deploy and operate high performance cloud and AI infrastructure at scale.